By BY PAULA SPAN from NYT Health https://ift.tt/3mfJxYB
Saturday, 2 October 2021
Friday, 1 October 2021
Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID
The drug maker claims clinical trials of its new antiviral pill molnupiravir shows the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.
from WebMD Health https://ift.tt/3l2Pid2
Two studies suggest that newer variants of the coronavirus are better at traveling through the air.
By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3D9c0q1
Summer camp outbreaks were concentrated around the unvaccinated, C.D.C. finds.
By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3kYthMk
Is the Coronavirus Getting Better at Airborne Transmission?
By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/3FcpPFO
